Sagility Ltd.
SAGILITY · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹39.89.
Piotroski F-score 7/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%10.3%
- ✓Low debt (D/E < 0.5)0.11x
- ✓Positive free cash flow
- ✓Revenue growth > 10%29%
- ✓Earnings growing44%
- ✓Net margin ≥ 10%12.9%
- ✓Current ratio > 1.51.55
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 4.46
- ✓Piotroski ≥ 77/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 4.46.
- •High Piotroski quality score (7/9).
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Earnings growing (44% YoY).
- •Revenue growing (29% YoY).
- •Trading in our value buy zone versus sector peers.
- •Trades ~25% below our estimated fair value.
About Sagility Ltd.
Sagility Limited engages in the provision of business process management services to the healthcare and insurance industries in India, Jamaica, the Philippines, the United States, and Colombia. The company offers claims cost containment and management, member and provider engagement, enrolment, benefits plan building, payment integrity and billing, credentialing, clinical and case management, provider network operation services, analytics, front and back-office, administrativ
More in Information Technology
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.